Details for Patent: 12,156,940
✉ Email this page to a colleague
Which drugs does patent 12,156,940 protect, and when does it expire?
Patent 12,156,940 protects EXPAREL and is included in one NDA.
Drugs Protected by US Patent 12,156,940
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pacira Pharms Inc | EXPAREL | bupivacaine | INJECTABLE, LIPOSOMAL;INJECTION | 022496-001 | Oct 28, 2011 | AP | RX | Yes | Yes | 12,156,940 | ⤷ Try for Free | Y | ||||
| Pacira Pharms Inc | EXPAREL | bupivacaine | INJECTABLE, LIPOSOMAL;INJECTION | 022496-002 | Oct 28, 2011 | AP | RX | Yes | Yes | 12,156,940 | ⤷ Try for Free | Y | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use |
Showing 1 to 2 of 2 entries
